Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onkogematologii͡a 2014-07, Vol.6 (2), p.4-7
Hauptverfasser: E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy
Format: Artikel
Sprache:rus
Schlagworte:
alemtuzumab
chronic lymphocytic leukemia
fludarabine
resistant patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.
ISSN:1818-8346
2413-4023
DOI:10.17650/1818-8346-2011-6-2-4-7